On January 19, Merck China entered into a memorandum of cooperation with M-ChemAI. Drawing on its advanced high-throughput automated laboratory and AI technology platform, M-ChemAI is set to offer chemical synthesis services to Merck China. This move aims to expedite molecular synthesis processes and significantly reduce product development timelines. In tandem, M-ChemAI will support Merck China in setting up localized AI and automated labs. Additionally, the two entities will collaborate to develop and locally deploy customized AI models tailored for Merck China, with a strong emphasis on ensuring data security and regulatory compliance.
